Table 1.
Characteristics of the 365 patients with diverticular bleeding
| 2007 | End of follow-up | |
|---|---|---|
| Total patients, n (%) | 365 (100%) | 365 (100%) |
| Age in years, mean (SD) | 79.5 ± 10.0 | 83.6 ± 9.7 |
| Male patients, n (%) | 184 (50.4%) | 184 (50.4%) |
| Median follow-up time,years (median and IQR) | 3.9 (IQR 25–75: 1.7–5.4) | |
| Mortality rate, n (%) | - | 148 (40.5%) |
| Initial comorbidity,Charlson’s score; mean (SD) | 2.8 ± 1.8 | - |
| History of diverticular bleeding (prior to 2007), n (%) | 48 (13.1%) | - |
| Anticoagulant or antiplatelet therapy,n (%) | 244 (66.8%) | 217 (59.4%) |
| Aspirin, n (%) | 135 (37.0%) | 115 (31.5%) |
| Clopidogrel, n (%) | 50 (13.7%) | 40 (11.4%) |
| Antivitamin K, n (%) | 102 (27.9%) | 91 (24.9%) |
| Bitherapya, n (%) | 41 (10.3%) | 28 (7.7 %) |
| No treatment, n (%) | 121 (33.2%) | 148 (40.5%) |
a
Bitherapy: various combinations of antiplatelet and/or anticoagulant drugs. Treatment at discharge from hospital in 2007.
IQR: interquartile range; n: number of patients